9 results COVID-19: fast-forwarding competition law Competition authorities are temporarily ‘green-lighting’ certain collaboration initiatives to safeguard the supply of essential products in light of the COVID-19 outbreak. Luxembourg introduces new State aid scheme for businesses affected by Covid-19 Following the Luxembourg government’s declaration of a state emergency and as part of the new measures in response to the consequences of the Covid-19 pandemic, the country has adopted a new law in an effort to support businesses suffering financially. Stibbe advises group of investors led by Joh. A. Benckiser Stibbe advised a group of investors led by Joh. A. Benckiser on its bid for all outstanding shares of D.E MASTER BLENDERS 1753 N.V. Stibbe advises Rhône Capital Stibbe advised Rhône Capital on its acquisition - and on the financing, tax, IP and employment aspects - of CSM’s Bakery Supplies business for an enterprise value of EUR 1,05 billion. The honeymoon phase of the Foreign Subsidies Regulation is over! Paperwork, paperwork, paperwork. The industry voices have been clear about the Foreign Subsidies Regulation. But what is the authority’s view? We provide an update on recent developments, including the European Commission’s first policy brief. No impairment of the EC’s impartiality: ECJ upholds Scania judgment The ECJ upheld the Commission’s fine on Scania for participating in a cartel. The Commission’s impartiality is not necessarily impaired by having the Commission case team in charge of the settlement procedure also deal with the penalty decision. First trip around the sun: FSR – one year in review The Foreign Subsidies Regulation has celebrated one year of its application. Time for companies to take stock of the lessons learnt from key developments of this first year. However, ambiguities remain and more is yet to come. Watch this space! The Commission’s ‘killer’ pharma campaign: reason to complain? The European Commission is on the prowl in the pharma sector. Recent cases on alleged disparagement and pipeline drugs-killings show that it is not afraid to show its teeth and, ultimately, bite. Digital antitrust conduct: too elusive to catch? The ink on the Digital Market Act has barely dried, but fast-evolving digital developments already have competition authorities calling for new tools. Is Big Tech not kept in check by the DMA, the antitrust rules and the EU Merger Regulation after all?
COVID-19: fast-forwarding competition law Competition authorities are temporarily ‘green-lighting’ certain collaboration initiatives to safeguard the supply of essential products in light of the COVID-19 outbreak.
Luxembourg introduces new State aid scheme for businesses affected by Covid-19 Following the Luxembourg government’s declaration of a state emergency and as part of the new measures in response to the consequences of the Covid-19 pandemic, the country has adopted a new law in an effort to support businesses suffering financially.
Stibbe advises group of investors led by Joh. A. Benckiser Stibbe advised a group of investors led by Joh. A. Benckiser on its bid for all outstanding shares of D.E MASTER BLENDERS 1753 N.V.
Stibbe advises Rhône Capital Stibbe advised Rhône Capital on its acquisition - and on the financing, tax, IP and employment aspects - of CSM’s Bakery Supplies business for an enterprise value of EUR 1,05 billion.
The honeymoon phase of the Foreign Subsidies Regulation is over! Paperwork, paperwork, paperwork. The industry voices have been clear about the Foreign Subsidies Regulation. But what is the authority’s view? We provide an update on recent developments, including the European Commission’s first policy brief.
No impairment of the EC’s impartiality: ECJ upholds Scania judgment The ECJ upheld the Commission’s fine on Scania for participating in a cartel. The Commission’s impartiality is not necessarily impaired by having the Commission case team in charge of the settlement procedure also deal with the penalty decision.
First trip around the sun: FSR – one year in review The Foreign Subsidies Regulation has celebrated one year of its application. Time for companies to take stock of the lessons learnt from key developments of this first year. However, ambiguities remain and more is yet to come. Watch this space!
The Commission’s ‘killer’ pharma campaign: reason to complain? The European Commission is on the prowl in the pharma sector. Recent cases on alleged disparagement and pipeline drugs-killings show that it is not afraid to show its teeth and, ultimately, bite.
Digital antitrust conduct: too elusive to catch? The ink on the Digital Market Act has barely dried, but fast-evolving digital developments already have competition authorities calling for new tools. Is Big Tech not kept in check by the DMA, the antitrust rules and the EU Merger Regulation after all?